Optimization of Methylene Blue Derivatives as Mitochondrial Therapeutic Agents for the Treatment of Freidreich's Ataxia

Project: Research project

StatusActive
Effective start/end date1/1/1812/31/19

Funding

  • Friedreich's Ataxia Research Alliance: $300,000.00